Sastre-Garriga, J <br/><br/>
Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.  [electronic resource] 

 -  Archives of neurology  Apr 2005 
 - 569-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-9942 
<br/><br/><label>Standard No.: </label>10.1001/archneur.62.4.569  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age of Onset<br/>Aged<br/>Aspartic Acid--analogs & derivatives<br/>Biomarkers<br/>Case-Control Studies<br/>Cerebral Cortex--metabolism<br/>Choline--analysis<br/>Disability Evaluation<br/>Disease Progression<br/>Female<br/>Glutamic Acid--metabolism<br/>Humans<br/>Inositol--analysis<br/>Magnetic Resonance Spectroscopy<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Chronic Progressive--diagnosis<br/>Nerve Fibers, Myelinated--metabolism<br/>Neurons--metabolism<br/>Neuropil--metabolism<br/>Phosphocreatine--analysis<br/>Predictive Value of Tests<br/>Reference Values<br/>Statistics as Topic